Allied with Genentech and Pfizer on discovery deals, protein degradation crew at Arvinas looks for $100M IPO ahead of PhI start
The next wave of biotech IPOs is starting to swell today as the protein degradation crew at Arvinas jumps in with a $100 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
